Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, ...

It’s become a common scene in the news and social media feeds: Federal immigration agents descend on day laborers seeking work outside of big box home improvement stores. Now so ...